Jennifer Price
UCSF
Appearances
DateMay 7, 2023It is controversial whether glucagon-like peptide 1 (GLP-1) receptor agonists (RA) are associated with adverse pancreatic, gallbladder or biliary outcomes…Presenter
Virginia Commonwealth Univ.Speakers
- DateMay 8, 2023SOCIETY: DDW
Presenter
UCSF - DateMay 7, 2023BACKGROUND: Non-alcoholic steatohepatitis (NASH), a leading cause of liver-related morbidity and mortality, is highly prevalent in people living with HIV (PLWH).1 Microbial translocation (MT) associated with hepatic inflammation and fibrosis may play a critical role in NASH pathogenesis…
DateMay 19, 2024SOCIETY: AASLDModerators
DateMay 21, 2024SOCIETY: AGA Updates and newer management strategies for portal hypertension in patients with liver disease…Moderators
Rutgers The State University of New JerseyUCSF
DateMay 5, 2025SOCIETY: AASLDModerators
University of MichiganUCSF- DateMay 3, 2025SOCIETY: AASLD
Moderators
UCSFUniversity of California San Diego - DateMay 6, 2025LIVE STREAM SESSION The session in common consults for hepatology will discuss and review treatment approaches to autoimmune hepatitis such as azathioprine, mycophenolate, budeesonide. In addition, recently approved medicaitons for PBC and MASLD will be discussed…
Moderators
UCSFCHS 
DateMay 5, 2025This session will provide an in-depth look at innovative approaches and models for improving outcomes in liver transplant patients…Moderators
Columbia University Medical CenterUCSF
